Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

FIT

- PMLiVE

Your essential guide to the World EPA Congress 2025: Top sessions and pre-reading

The World EPA organisers have curated an exceptional programme featuring thought-provoking presentations and dynamic panel sessions led by industry leaders driving market access strategy and practice. Following the opening keynote...

Petauri Evidence

- PMLiVE

Uniphar Expands Global Footprint with Three New Facilities in the USA, Netherlands and Ireland

[Dublin, 05 February 2025] Global partner to pharmaceutical and medtech manufacturers, Uniphar, is expanding its international presence with the launch of three new, state-of-the-art facilities, strategically positioned across key global...

Uniphar

- PMLiVE

What does HEOR really mean in 2025?

Global healthcare systems are under unprecedented strain. As life expectancies rise and populations age, the proportion of people aged 60+ years is expected to soar. This both signals remarkable progress...

Petauri Evidence

- PMLiVE

Meet the Petauri experts at World EPA Congress

We are delighted to announce that market access and HEOR experts from Mtech Access - Powered by Petauri will be attending World Evidence, Pricing and Access Congress in Amsterdam on...

Petauri Evidence

- PMLiVE

Uniphar appoints industry leader, Isaac Batley, as Global Head of Scientific Communications

Isaac Batley, an experienced CEO with 35 years’ experience within healthcare and pharmaceutical communications, joins Uniphar to spearhead its medical communications division.

Uniphar

- PMLiVE

Health economics training unpacked: A conversation with the trainers

Did you know we offer a suite of education and training options? Our workshops, insight sessions, and training help Pharma and Medtech teams upskill in key HEOR disciplines and prepare...

Petauri Evidence

Challenges for orphan medicines entering the European market

We explore the various challenges facing orphan medicines entering the European market and offer solutions to help improve patient access.

Petauri Evidence

Ispor Europe poster winning authors

Genesis Research Group’s ISPOR Europe award-winning poster authors interviewed online

Genesis Research Group's poster 'Payer Perspective on the Impact of Real-world Evidence in Health Technology Assessments of Precision Oncology Treatments Across Europe: Results From an Online Survey' was recently named as...

Genesis Research Group

- PMLiVE

From molecule to market and beyond: Uniphar announces extended global commercialization platform

Healthcare services business, Uniphar, has developed its full-service offering that harnesses Uniphar’s 57 years in the industry delivering specialist services to more than 200 international clients across 180 countries.

Uniphar

- PMLiVE

Mtech Access are exhibiting at ISPOR in Europe

• Mtech Access – Powered by Petauri™ are excited to be returning to ISPOR Europe this November. The team will be joined by colleagues from across Petauri, including Delta Hat...

Petauri Evidence

- PMLiVE

Navigating US payer evidence needs to optimise market access

What clinical and economic evidence do US payers prefer to drive formulary decisions? How can you optimise your chances of preferential access in the US with the right evidence? How...

Petauri Evidence

- PMLiVE

2024 updates to the ABPI Code of Practice Clause 12

Iain Shield (Associate Director – Market Access, Mtech Access) has reviewed the changes to the ABPI Code of Practice, and highlights updates to prescribing information (Clause 12) and considerations around...

Petauri Evidence

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links